Global Remote Patient Monitoring Systems Industry

Global Remote Patient Monitoring Systems Industry

  • April 2021 •
  • 269 pages •
  • Report ID: 5818127 •
  • Format: PDF
Abstract:
- Global Remote Patient Monitoring Systems Market to Reach $1.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Remote Patient Monitoring Systems estimated at US$745.7 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at aCAGR of 12.9% over the period 2020-2027. Vital Sign Monitors, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$524.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Special Monitors segment is readjusted to a revised 12.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $220.4 Million, While China is Forecast to Grow at 12.4% CAGR
- The Remote Patient Monitoring Systems market in the U.S. is estimated at US$220.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$302.8 Million by the year 2027 trailing a CAGR of 12.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 10.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

- Select Competitors (Total 83 Featured) -
  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.